AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 191 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $91,000 | +23.0% | 9,628 | 0.0% | 0.00% | – |
| Q2 2020 | $74,000 | +23.3% | 9,628 | 0.0% | 0.00% | – |
| Q1 2020 | $60,000 | -45.9% | 9,628 | +5.1% | 0.00% | -100.0% |
| Q4 2019 | $111,000 | +4.7% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $106,000 | +16.5% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $91,000 | -22.9% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $118,000 | -15.1% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $139,000 | -24.0% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $183,000 | +2.2% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $179,000 | -3.2% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $185,000 | +52.9% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $121,000 | -28.4% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $169,000 | 0.0% | 9,158 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $169,000 | -18.4% | 9,158 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $207,000 | -35.1% | 9,158 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $319,000 | +41.2% | 9,158 | -0.7% | 0.00% | +50.0% |
| Q3 2016 | $226,000 | +2.3% | 9,227 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $221,000 | +2.3% | 9,227 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $216,000 | -22.6% | 9,227 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $279,000 | -24.0% | 9,227 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $367,000 | -42.4% | 9,227 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $637,000 | +26.4% | 9,227 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $504,000 | +10.5% | 9,227 | -13.8% | 0.00% | 0.0% |
| Q4 2014 | $456,000 | +33.3% | 10,709 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $342,000 | +54.1% | 10,709 | 0.0% | 0.00% | +50.0% |
| Q2 2014 | $222,000 | +7.2% | 10,709 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $207,000 | -20.4% | 10,709 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $260,000 | +13.0% | 10,709 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $230,000 | -3.4% | 10,709 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $238,000 | – | 10,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |